Enhanced phenotypic and functional maturation of monocyte-derived dendritic cells from patients with active crohn's disease and ulcerative colitis

Journal of Physiology and Pharmacology

Volumn 61, Issue 6, 2010, Pages 695-703

  Radwan, P ^a   Radwan Kwiatek, K ^a   Tabarkiewicz, J ^a   Radej, S ^a   Rolinski, J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Dendritic cells; Inflammatory bowel disease; Lipopolisaccharide; Monocyte; Tumor necrosis factor alpha

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL MATURATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MONOCYTE DERIVED DENDRITIC CELL; ULCERATIVE COLITIS;

ADULT; ANTIGENS; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; DENDRITIC CELLS; ESCHERICHIA COLI; FEMALE; HUMANS; HYDROCORTISONE; IMMUNOPHENOTYPING; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79251587795     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Niess JH. Role of mucosal dendritic cells in inflammatory bowel disease. World J Gastroenterol 2008; 14: 5138-5148.
2. Stagg AJ, Hart AL, Knight SC, Kamm MA. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 2003; 52: 1522-1529.
3. Bilsborough J, Viney JJ. Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 2004; 127: 300-309.
4. Silva MA. Intestinal dendritic cells and epithelial barrier dysfunction in Crohn's disease. Inflamm Bowel Dis 2009; 15: 436-453.
5. Kelsall BL, Leon F. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunol Rev 2005; 206: 132-148.
6. Middel P, Raddatz D, Gunawan B, Haller F, Radzun HJ. Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut 2006; 55: 220-227.
7. Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4; three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165: 6037-6046.
8. Vuckovic S, Florin TH, Khalil D, et al. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 2946-2956.
9. Baumgart DC, Metzke D, Schmitz J. et al. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 2005; 54: 228-236.
10. Radwan-Kwiatek K, Tabarkiewicz J, Radwan P, et al. CD1c+/CD19- and CD303+/CD123+ dendritic cells in the peripheral blood in patients with ulcerative colitis and Crohn's disease. Pol J Environ Studies 2007; 16(5C, part II): 526-529.
11. Radwan-Kwiatek K, Radwan P, Tatarkiewicz J. et al. Circulating dendritic cells as a novel disease activity marker in inflammatory bowel disease? Gut 2009; 58(Suppl II): A258.
12. Leon B, Ardavin C. Monocyte-derived dendritic cells in innate and adaptive immunity. Immunol Cell Biol 2008; 86: 320-324.
13. Varol C, Landsman L, Fogg DK, et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med 2007; 204: 171-180.
14. Agger R, Petersen S, Tolbod HE, et al. Characterization of murine dendritic cells derived from adherent blood mononuclear cells in vitro. Scand J Immunol 2000; 52: 138-147.
15. Ikeda Y, Akbar SM, Matsui H, Onji M. Antigen-presenting dendritic cells in ulcerative colitis. J Gastroenterol 2002; 37 (suppl XIV): 53-55.
16. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369: 1641-1657.
17. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444.
18. D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007; 132: 763-786.
19. Hart AL, Al-Hassi HO, Rigby RL, et al. Characteristics of intestinal dendritic cells in inflammatory bowel disease. Gastroenterology 2005; 129: 50-65.
20. Facci M, Auray G, Buchanan R, et al. A comparison between isolated blood dendritic cells and monocyte derived dendritic cells in pigs. Immunology 2010; 129: 396-405.
21. Wu Z, Rothwell L, Young JR, Kaufman J, Butter C, Kaiser P. Generation and characterization of chicken bone marrow derived dendritic cells. Immunology 2010; 129: 133-145.
22. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
23. Latvala S, Pietilla TE, Veckman V, et al. Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J Gastroenterol 2008; 14: 5570-5583.
24. Hart AL, Lammers K, Brigidi P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53: 1602-1609.
25. Kaszuba-Zwoinska J, Ciecko-Michalska I, Madroszkiewicz D, et al. Magnetic field anti-inflammatory effects in Crohn's disease depends upon viability and cytokine profile of the immune competent cells. J Physiol Pharmacol 2008; 59: 177-187.
26. Mahida YR, Rolfe VE. Host-bacterial interactions in inflammatory bowel disease. Clin Sci 2004; 107: 331-341.
27. Swidsinski A, Loening-Baucke V, Herber A. Mucosal flora in Crohn's disease and ulcerative colitis - an overview. J Physiol Pharmacol 2009; 60(Suppl 6): 61-71.
28. Salucci V, Rimoldi M, Penati C, et al. Monocyte-derived dendritic cells from Crohn patients show differential NOD2/CARD15-dependent immune responses to bacteria. Inflamm Bowel Dis 2008; 14: 812-818.
29. Gogolak P, Rethi B, Szatmari I, et al. Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARgamma. Blood 2007; 109: 643-652.
30. Chang CC, Wright A, Punnonen J. Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J Immunol 2001; 165: 3584-3591.
31. Cernadas M, Lu J, Watts G, Brenner MB. CD1a expression defines an interleukin-12 producing population of human dendritic cells. Clin Exp Immunol 2009; 155: 523-533.
32. Kato M, Neil TK, Fearnley DB, McLellan AD, Vuckovic S, Hart DN. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int Immunol 2000; 12: 1511-1519.
33. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. Regulation of toll-like receptors in human monocytes and dendritic cells. J Immunol 2001; 166: 249-255.
34. de Jong EC, Vieira PL, Kalinski P, Kapsenberg ML. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol 1999; 66: 201-204.
35. Bosma BM, Metselaar HJ, Nagtzaam NM, et al. Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells. Immunology 2008; 125: 91-100.